0.4951.02% ( +0.005 )
Delay Closed: Nov 17, 16:08:15Financials
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: MABPHARM-B(02181) the Revenue is 229.82 M (+52.99%);the EBIT is 19.59 M (+1150%);the EPS is 0.0044 (+1042%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.23B52.99%
----
----
EBIT
0.02B1149.99%
----
----
EPS
0.00441041.78%
----
----
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateNov 27, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
